By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Tissue supply firm Asterand today said that its BioSeek subsidiary will provide its BioMap predictive human disease models to Cellzome for use in its inflammatory disease drug discovery projects.

The BioMap platform will be used to predict possible human clinical responses to small molecules identified by Cellzome using its own Kinobeads and Episphere screening and profiling technologies. The agreement is for two years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.